Lisinopril
- Product NDC
- 0603-4214
- 11-digit product format
- 006034214
- Labeler code
- 0603
- Product ID
- 0603-4214_434b11ef-3ccb-4284-ba8b-14ceea66e030
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Par Pharmaceutical
- Application
- ANDA075743
- Marketing category
- ANDA
- Marketing start
- 2002-07-01
- Marketing end
- 2019-04-30
- Substance
- LISINOPRIL
- Active strength
- 40 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f8f05a6d-f74b-4e9e-ab1c-374d3b4fb820 | Product name | 1 | 20230703 |
| f65307a7-3644-0a09-cdfd-94aae8d3b53e | Product name | 3 | 20210902 |
| 1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3d | Product name | 2 | 20170719 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0603-4214-02 | EA - Each | 0603-4214 | 81c25274-2365-4ae3-b0da-f55c5507e18f | 1 | 2012-07-24 |
| 0603-4214-04 | EA - Each | 0603-4214 | 79ec7675-6215-43dd-b2eb-efc01ce74fe4 | 1 | 2012-07-24 |
| 0603-4214-21 | EA - Each | 0603-4214 | 3a9f1844-5dee-40e9-a0dc-8a316a53fb43 | 1 | 2012-07-24 |
| 0603-4214-28 | EA - Each | 0603-4214 | 142840ab-77d6-4dde-99ba-68361acd9a75 | 1 | 2012-07-24 |
| 0603-4214-30 | EA - Each | 0603-4214 | c5db2fb1-1d7c-4d91-bdbb-04b7b719fbf5 | 1 | 2012-07-24 |
| 0603-4214-32 | EA - Each | 0603-4214 | f8e9bea9-c098-4d94-b575-4fa60e1a0fdf | 1 | 2012-07-24 |
| 0603-4214-60 | EA - Each | 0603-4214 | 9c437561-10e0-4e39-bdc3-8c2c75240944 | 1 | 2012-07-24 |